[Insufficient blood pressure control following coronary revascularization]

Natasha Roseva-Nielsen1, Kjeld Kristensen, Ulrik Talleruphuus

  • 1Kardiologisk Afdeling, Holbaek Sygehus, DK-4300 Holbaek. ngr@regionsjaelland.dk

Ugeskrift for Laeger
|March 17, 2009
PubMed

Insights

Blood pressure control is often poor in patients after coronary revascularization, with about half experiencing elevated readings. This highlights a need for improved management strategies post-procedure to ensure better cardiovascular health outcomes.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Post-Coronary Revascularization Care

Context:

  • Following coronary revascularization, patients often experience increased blood pressure (BP) due to reduced anti-angina treatment and improved ejection fraction.
  • Suboptimal BP control poses a significant risk for cardiovascular events in this patient population.

Purpose:

  • To evaluate the status of blood pressure (BP) control in patients at least 12 months after undergoing coronary revascularization procedures.
  • To identify the prevalence of uncontrolled hypertension in patients post-revascularization.

Summary:

  • A study of 190 patients post-revascularization revealed that 42.6% had uncontrolled BP by clinic measurements and 51.6% by ambulatory monitoring.
  • Among diabetic patients, uncontrolled BP was even higher (64.3% clinic, 75.0% ambulatory).
  • High BMI, elevated cholesterol, and continued smoking were prevalent, contributing to poor BP control.

Impact:

  • The findings indicate unsatisfactory blood pressure control in a significant proportion of patients after revascularization.
  • This underscores the critical need for enhanced BP monitoring and management strategies in the long-term care of these individuals.
  • Improved hypertension management post-revascularization could reduce the risk of recurrent cardiovascular events.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...